Location History:
- Tustin, CA (US) (1999)
- Closter, NJ (US) (2020)
- Santa Ana, CA (US) (1992 - 2023)
- Anaheim, CA (US) (2019 - 2024)
Company Filing History:
15 out of 2,285 
8 out of 8 
4 out of 11 Years Active: 1992-2025
Title: Innovations and Contributions of John Y. Park in Peptide Therapies
Introduction
John Y. Park, a prolific inventor based in Santa Ana, California, has made significant contributions to the field of peptide therapies, with a remarkable portfolio of 31 patents. His innovative work focuses on developing compounds that target various medical conditions, particularly in ophthalmology, showcasing his expertise and dedication to advancing healthcare.
Latest Patents
Among his latest patents, Park has developed novel peptide therapies aimed at reducing macular thickening. These patents include compounds comprising R-G-Cysteic Acid, specifically R-G-NH—CH(CH—SOH)COOH or Arg-Gly-NH—CH(CH—SOH)COOH, as well as their derivatives, which encompass pharmaceutically acceptable salts, hydrates, stereoisomers, multimers, cyclic forms, linear forms, drug-conjugates, pro-drugs, and their derivatives. He has also disclosed methods for utilizing these compounds, which involve inhibiting integrins, preventing or treating viral or microbial infections, and delivering therapeutic agents to RGD binding sites in both human and animal subjects.
Career Highlights
Throughout his career, John Y. Park has been affiliated with esteemed companies such as Allergan, Inc. and Allegro Pharmaceuticals, LLC. His work with these organizations has allowed him to further innovate and refine his research in peptide therapies, contributing to advancements in the pharmaceutical domain.
Collaborations
Park's collaboration with prominent colleagues, including Anthony J. Dziabo and James N. Cook, has enriched his research endeavors. These partnerships have facilitated a deeper exploration into peptide therapies and have undoubtedly contributed to the success of his patented inventions.
Conclusion
In conclusion, John Y. Park stands out as a notable inventor in the field of peptide therapies, with numerous patents that demonstrate his commitment to improving health outcomes. His innovative approach, career accomplishments, and valuable collaborations highlight his significant impact on the life sciences and pharmaceutical industries.